Rule changes include mandating ORELAP to accredit laboratories, stricter sample collection rules and more comprehensive pesticide testing requirements.
State legal protections and medical research should spur insurance companies to tackle cannabis.
Dr. Schwartz hopes to use genetic variations and marker-assisted breeding to provide cannabis as a more precise medical treatment.
The stigma associated with cannabis and its federal illegality prevent the normalization of cannabis business.
Using the defense of deeming contracts void based on illegality in litigation could set dangerous precedents for the industry going forward.
Quality is not just tested for in the final product, but built into each step of the manufacturing process.
On their 42-acre farm, Jacques and his team are strain-testing and formulating customizable cannabis oils for individual patients.
Employee training, consumer education, the customer experience and inventory management are key to improving retail operations.
States like New York, Massachusetts, Pennsylvania and Connecticut could quickly become hubs for the medical cannabis industry.
The best way to avoid recalls from occurring is using preventative strategies like HACCP and GMP’s.
